| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/01/2007 | US20070027187 Vanilloid receptor (VR1) antagonists; side effects reduction, oral availability; To treat urinary incontinence, urge urinary incontinence, overactive bladder, pain, and/or inflammatory diseases such as asthma and COPD; N-[2-(2-Fluorophenoxy)ethyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)-urea |
| 02/01/2007 | US20070027179 Azaindole derivatives, preparations thereof, uses thereof and compositions containing them |
| 02/01/2007 | US20070027174 Phenylalanine Enamide Derivatives |
| 02/01/2007 | US20070027157 Quinoxalinone-3-one derivatives as orexin receptor antagonists |
| 02/01/2007 | US20070027139 Piperazinyl-quinoline derivatives useful for the treatment of cns disorders |
| 02/01/2007 | US20070027138 Derivatives and analogs of galanthamine |
| 02/01/2007 | US20070027090 Methods of treating cognitive dysfunction by modulating brain energy metabolism |
| 02/01/2007 | US20070026494 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026470 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026389 Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| 02/01/2007 | US20070026054 Medicament preparations for transdermal application containing active ingredient combinations for treating parkinson's disease |
| 02/01/2007 | US20070026007 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent |
| 02/01/2007 | US20070025989 Administration of agents for the treatment of inflammation |
| 02/01/2007 | US20070025971 Substances causing differentiation |
| 02/01/2007 | US20070025970 Vector system |
| 02/01/2007 | US20070025959 Adjuvant combination formulations |
| 02/01/2007 | DE10301917B4 Verwendung von Substanzen der Porphyrinsynthese bei der Phototherapie von Haut- oder Gelenkerkrankungen des Menschen oder von Säugetieren Use of substances of the porphyrin synthesis in the phototherapy of skin or joint disease of humans or mammals |
| 02/01/2007 | DE102005033645A1 Pharmazeutischer Wirkstoff-Kombination zur Behandlung von Multipler Sklerose Pharmaceutical drug combination for the treatment of multiple sclerosis |
| 02/01/2007 | CA2617183A1 Use of nefopam for the treatment of affective disorders |
| 02/01/2007 | CA2616576A1 Substituted triazole derivatives and their use as neurokinin 3 receptor antagonists |
| 02/01/2007 | CA2616547A1 Quinoline derivatives as neurokinin receptor antagonists |
| 02/01/2007 | CA2616377A1 Nitrocatechol derivatives as comt inhibitors |
| 02/01/2007 | CA2616328A1 A medicine to treat drug addiction and preparation method thereof |
| 02/01/2007 | CA2616004A1 Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders |
| 02/01/2007 | CA2615946A1 Pyrazolo pyrimidines useful as aurora kinase inhibitors |
| 02/01/2007 | CA2615774A1 Large substituent, non-phenolic opioids |
| 02/01/2007 | CA2615474A1 Method for treating nervous system disorders and conditions |
| 02/01/2007 | CA2581831A1 Pharmaceutical compositions comprising levetiracetam and process for their preparation |
| 01/31/2007 | EP1748069A1 Follistatin mutant polypeptide |
| 01/31/2007 | EP1748048A1 Imidazopyridine compound |
| 01/31/2007 | EP1748043A1 Polysubstituted 1,1-pyridinyloxycyclopropanamine derivatives, process for their préparation and pharmaceutical compositions containing them |
| 01/31/2007 | EP1747277A1 Method for gene delivery to neuronal cells |
| 01/31/2007 | EP1747210A1 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands |
| 01/31/2007 | EP1747202A1 Indazole derivatives and pharmaceutical compositions containing them |
| 01/31/2007 | EP1747195A1 Sulfonamide compounds for the treatment of neurodegenerative disorders |
| 01/31/2007 | EP1747191A1 Substituted cyclohexyl-1,4-diamine derivatives with a chain extension |
| 01/31/2007 | EP1746994A2 Thienopyridinone compounds and methods of treatment |
| 01/31/2007 | EP1746991A2 Daao inhibiting benzisoxazoles for treating mental disorders |
| 01/31/2007 | EP1746983A2 Use of ghrelin antagonists for improving cognition and memory |
| 01/31/2007 | EP1746982A2 Histone deacetylases inhibitors against hyperlipidaemias, atherosclerosis and cardiovascular diseases |
| 01/31/2007 | EP1587801B1 A process for preparing duloxetine and intermediates for use therein |
| 01/31/2007 | EP1478357B1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 01/31/2007 | EP1194138B1 Nutritional supplements |
| 01/31/2007 | EP0804574B1 Human kappa opioid receptor, nucleic acids and uses thereof |
| 01/31/2007 | CN1906187A 5-fluoro-, chloro- and cyano-pyridin-2-yl-tetrazoles as ligands of the metabotropic glutamate receptor-5 |
| 01/31/2007 | CN1906176A Therapeutic agents II |
| 01/31/2007 | CN1906174A Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 01/31/2007 | CN1906170A 7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepinium maleate or tosylate as antipsychotics |
| 01/31/2007 | CN1906169A Therapeutic agents I |
| 01/31/2007 | CN1906167A Novel pyridine derivative and pyrimidine derivative (2) |
| 01/31/2007 | CN1906166A Novel pyridine derivative and pyrimidine derivative (1) |
| 01/31/2007 | CN1906160A Imidazole derivatives, processes for preparing them and their uses |
| 01/31/2007 | CN1905901A Erythrocyte function modifying substance |
| 01/31/2007 | CN1905879A Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an N-methyl-D-aspartate (NMDA) receptors antagonist |
| 01/31/2007 | CN1903844A New polysubstituted 1, 1pyridylaminocyclopropanamine compounds,a process for their preparation and pharmaceutical compositions containing them |
| 01/31/2007 | CN1903843A New polysubstituted 1,1-pyridyloxycyclopropanamine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 01/31/2007 | CN1903835A Compound, composition and method for preventing neurodegeneration in acute and chronic injury of central nervous system |
| 01/31/2007 | CN1903342A Extractive of flowers and leaves of pseudo-ginseng, prepn. method, quality control method and application thereof |
| 01/31/2007 | CN1903327A Traditional Chinese medicine for treating epilepsy |
| 01/31/2007 | CN1903315A Active parts of fibrous root of Radix ophiopogonis, prepn. method and use thereof |
| 01/31/2007 | CN1903314A Traditional Chinese medicine composition for treating head-ache, ahypnia, palpitate and feeble, and its prepn. method |
| 01/31/2007 | CN1903313A Traditional Chinese medicine pills for dispelling stagancy and eliminating phlegm, and its prepn. method |
| 01/31/2007 | CN1903294A Traditional Chinese medicine having functional of supplementing qi, disintoxication, expelling knot and harmonizing stomach, its prepn. method |
| 01/31/2007 | CN1903267A Traditional Chinese medicine decoction Buyang Xiaoshuan Huanwu Tang for tonifying yang and dissolving thrombus |
| 01/31/2007 | CN1903263A Traditional Chinese medicine for treating oral paralysis and preparing process thereof |
| 01/31/2007 | CN1903250A Method for extraction and separation of red rooted salvia |
| 01/31/2007 | CN1903243A Guhong control-release tablets and prepn. method therefor |
| 01/31/2007 | CN1903239A Method for extraction and separation of rhizome of chuanixong |
| 01/31/2007 | CN1903229A Ultrasonic process for extracting pine needle total flavone |
| 01/31/2007 | CN1903223A Antineoplastic medicine preparation and prepn. method therefor |
| 01/31/2007 | CN1297559C Fused bicyclic pyrimidine derivatives |
| 01/31/2007 | CN1297554C Amido ether substituted imidazoquinolines |
| 01/31/2007 | CN1297550C Benzofuran derivatives, process for the preparation of the same and uses thereof |
| 01/31/2007 | CN1297548C Cyclic hemiacetal derivative and use thereof |
| 01/31/2007 | CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 01/31/2007 | CN1297302C Extract of cocoa tea in application for preparing medication of foodstuff of preventing and improving fatigue and clinical symptom |
| 01/31/2007 | CN1297291C Medicine for abstaining from drug addiction and its preparation |
| 01/31/2007 | CN1297217C Application of Palatinose for pereparing brain Alpha wave emitting enhancing agent and food |
| 01/30/2007 | US7169929 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/30/2007 | US7169928 central nervous system disorders; Alzheimer's disease; attention deficit disorders; cognition activators; psychological disorders; antidepressants |
| 01/30/2007 | US7169924 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
| 01/30/2007 | US7169899 Cyclic lactams comprising three amino acids and a tether chain to control the overall shape of the macromolecule; beta-turn mimetics to explore conformationally restricted structures; proteolytic enzyme resistance (nonhydrolyzing); cell penetration; anticoagulants; anticarcinogenic agents |
| 01/30/2007 | US7169817 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 01/30/2007 | US7169798 Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases |
| 01/30/2007 | US7169794 Oxidation of a chemical intermediate |
| 01/30/2007 | US7169790 5-substituted 2-aryl-4-pyrimidinones |
| 01/30/2007 | US7169787 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
| 01/30/2007 | US7169786 Strong anti-depressant activity without being sedative; serotonin (5-HT) reuptake inhibitor activity in combination with additional alpha 2-adrenoceptor antagonist activity |
| 01/30/2007 | US7169782 Aryl substituted thiazolidinones and the use thereof |
| 01/30/2007 | US7169779 Inhibitors of p38 |
| 01/30/2007 | US7169778 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents |
| 01/30/2007 | US7169746 For effecting mental control through psycho-sedation or psycho-stimulation |
| 01/30/2007 | US7169603 Nucleic acid; a nucleotide sequence encoding a fusion polypeptide; fusion polypeptides containing alpha -MSH can be used to elicit a variety of biological responses, in vitro and in vivo |
| 01/30/2007 | US7169565 Isolated antibody that specifically binds to a polypeptide encoded by polynucleotides composed of any polyribonucleotide or polydeoxribonucleotide, which may be unmodified RNA or DNA or modified RNA or DNA |
| 01/30/2007 | US7169559 Using low density lipoprotein related proteins (LRP) to diagnose, treat and prevent paget's, osteoporosis, cirrhosis and rickets |
| 01/30/2007 | US7169412 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 01/30/2007 | US7169389 Human CD154 binding molecules and treatment methods |
| 01/30/2007 | US7169378 Delivery of opioids through an inhalation route |
| 01/30/2007 | US7168597 Aerosol metering valve |
| 01/30/2007 | CA2394861C N6 heterocyclic 8-modified adenosine derivatives |